As you all know, Alnylam is pioneering an entirely new class of medicines to treat human disease. This generational technology leverages the mechanism of RNA interference, a natural process of gene ...

Area of focus: translational research in vascular biology, including studies on endothelial cells, platelets and other blood cells. When a patient presented with challenging nosebleeds and severe ...

The Fostering Effective Diagnosis and Treatment for Underserved Populations with Bleeding Disorders Act would expand research, provider education, and awareness of bleeding disorders in women and ...

“These autosomal diseases, from an inheritance standpoint, affect men and women equally, but because of their impact on the gynecological system and menses, women are often affected much more than men ...

Hemab Therapeutics' $157 million series C follows a $135 million series B funding round in 2023. (iStock / Getty Images Plus) With a $157 million series C funding round, Hemab Therapeutics is looking ...

(Family Features) Many people don’t think much about whether their blood is clotting properly. However, when you have a bleeding disorder, a condition that affects the way your body controls clots, it ...

The “Educate to Elevate” campaign website includes educational information about bleeding disorders as well as a series of videos and articles tackling issues relevant to people with the conditions.

People with bleeding disorders like hemophilia may need blood transfusions from time to time. Donating blood may not be possible due to safety concerns. Hemophilia is a complex type of bleeding ...

Currently, there is a spike in cases of women being diagnosed with clotting factor deficiency, a condition where the blood does not clot properly. Many women aren’t aware of this and tend to dismiss ...

Bleeding Disorder Testing Market Driven by Rising Adoption of Reagents & Consumables, Expanding Hospital Procurement, Hemophilia Testing Demand, and Regulatory-Compliant Diagnostic Infrastructure to ...